Concepedia

A pilot study of atorvastatin treatment in dyslipemid, non‐alcoholic fatty liver patients

Elena Gómez Domínguez, Javier P. Gisbert, J.A. Moreno-Monteagudo, Luisa Garcı́a-Buey, Ricardo Moreno‐Otero

Alimentary Pharmacology & Therapeutics · 2006 · 188 citations · 20 references

Abstract

Serum aminotransferase and lipid levels were reduced significantly in all patients with atorvastatin treatment. Therapy with atorvastatin in NAFLD patients with hyperlipidemia was found to be both effective and safe.

References

20

Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆

Christi A Matteoni, Zobair M. Younossi, T GRAMLICH et al. · Gastroenterology · 1999 · 3.4K citations

Obesity, Metabolic Syndrome, Metabolic Associated Steatohepatitis +12

The Natural History of Nonalcoholic Steatohepatitis: A Follow–Up Study of Forty–Two Patients for Up to 21 Years

Elizabeth E. Powell, Graham Cooksley, Reginald G. Hanson et al. · Hepatology · 1990 · 1.5K citations

Cryptogenic Cirrhosis: Clinical Characterization and Risk Factors for Underlying Disease

Stephen H. Caldwell, David H. Oelsner, Julia C. Iezzoni et al. · Hepatology · 1999 · 1.1K citations · Full text

Gastroenterology, Pathology, Cryptogenic Cirrhosis +20

Nonalcoholic steatohepatitis: An expanded clinical entity

Bruce R. Bacon, M J Farahvash, Christine G. Janney et al. · Gastroenterology · 1994 · 1.1K citations

Metabolic Associated Steatohepatitis, Hepatology, Metabolic Associated Steatotic Liver Disease +8

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver

Takato Ueno, Hiroshi Sugawara, Koodo Sujaku et al. · Journal of Hepatology · 1997 · 613 citations

Obesity, Metabolic Syndrome, Nutrition +15